Cargando…

Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States

BACKGROUND: Cold agglutinin disease (CAD) is a rare, chronic form of autoimmune hemolytic anemia. Clinical manifestations can include classical complement pathway-mediated chronic hemolysis, anemia, and profound fatigue. Research has shown that patients with other anemias may develop anxiety and dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Broome, Catherine M., Hooda, Naushin, Su, Jun, Jiang, Xiaohui, Nicholson, Gina, Frankenfeld, Cara L., Iglesias-Rodriguez, Melitza, Fryzek, Jon, Patel, Parija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754177/
https://www.ncbi.nlm.nih.gov/pubmed/36520848
http://dx.doi.org/10.1371/journal.pone.0276617
_version_ 1784851126012608512
author Broome, Catherine M.
Hooda, Naushin
Su, Jun
Jiang, Xiaohui
Nicholson, Gina
Frankenfeld, Cara L.
Iglesias-Rodriguez, Melitza
Fryzek, Jon
Patel, Parija
author_facet Broome, Catherine M.
Hooda, Naushin
Su, Jun
Jiang, Xiaohui
Nicholson, Gina
Frankenfeld, Cara L.
Iglesias-Rodriguez, Melitza
Fryzek, Jon
Patel, Parija
author_sort Broome, Catherine M.
collection PubMed
description BACKGROUND: Cold agglutinin disease (CAD) is a rare, chronic form of autoimmune hemolytic anemia. Clinical manifestations can include classical complement pathway-mediated chronic hemolysis, anemia, and profound fatigue. Research has shown that patients with other anemias may develop anxiety and depression, but this has not been studied previously in patients with CAD. METHODS: CAD patients were identified in the Optum Claims-Clinical dataset (between January 1, 2006–June 30, 2016) and matched to comparison patients without CAD by patient factors. Adjusted Cox regression models estimated time to anxiety and depression, defined by three different outcomes: medication use, hospitalization, and therapy related to anxiety and depression. Subset analyses were performed for primary CAD. Patients were followed until they had anxiety and depression, they left the Optum system, death, or the study period ended (June 30, 2016). RESULTS: Patients with CAD (n = 384) were more likely to have medically attended anxiety and depression (adjusted hazard ratio [aHR]: 1.6; 95% confidence interval [CI]: 1.3–2.1), to be prescribed antidepressants or psychotherapy after their CAD diagnosis (aHR: 1.8; 95% CI: 1.2–2.9), or to be hospitalized for an anxiety and depression-related event along with medication or psychotherapy (aHR: 2.0; 95% CI: 1.4–2.9) relative to matched comparisons (n = 2789), during the follow-up period. Patients with primary CAD were at increased risk for medically attended anxiety and depression (aHR: 1.8; 95% CI: 1.4–2.4), with the highest risk for prescription medication or therapy (aHR: 2.7; 95% CI: 1.6–4.6). CONCLUSIONS: Our study indicates that medically attended anxiety and depression manifest at a higher rate in CAD patients than in a matched non-CAD cohort. Study findings suggest that CAD patients may experience a greater burden on mental health that may negatively contribute to their overall quality of life. Further investigation on this topic is warranted.
format Online
Article
Text
id pubmed-9754177
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-97541772022-12-16 Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States Broome, Catherine M. Hooda, Naushin Su, Jun Jiang, Xiaohui Nicholson, Gina Frankenfeld, Cara L. Iglesias-Rodriguez, Melitza Fryzek, Jon Patel, Parija PLoS One Research Article BACKGROUND: Cold agglutinin disease (CAD) is a rare, chronic form of autoimmune hemolytic anemia. Clinical manifestations can include classical complement pathway-mediated chronic hemolysis, anemia, and profound fatigue. Research has shown that patients with other anemias may develop anxiety and depression, but this has not been studied previously in patients with CAD. METHODS: CAD patients were identified in the Optum Claims-Clinical dataset (between January 1, 2006–June 30, 2016) and matched to comparison patients without CAD by patient factors. Adjusted Cox regression models estimated time to anxiety and depression, defined by three different outcomes: medication use, hospitalization, and therapy related to anxiety and depression. Subset analyses were performed for primary CAD. Patients were followed until they had anxiety and depression, they left the Optum system, death, or the study period ended (June 30, 2016). RESULTS: Patients with CAD (n = 384) were more likely to have medically attended anxiety and depression (adjusted hazard ratio [aHR]: 1.6; 95% confidence interval [CI]: 1.3–2.1), to be prescribed antidepressants or psychotherapy after their CAD diagnosis (aHR: 1.8; 95% CI: 1.2–2.9), or to be hospitalized for an anxiety and depression-related event along with medication or psychotherapy (aHR: 2.0; 95% CI: 1.4–2.9) relative to matched comparisons (n = 2789), during the follow-up period. Patients with primary CAD were at increased risk for medically attended anxiety and depression (aHR: 1.8; 95% CI: 1.4–2.4), with the highest risk for prescription medication or therapy (aHR: 2.7; 95% CI: 1.6–4.6). CONCLUSIONS: Our study indicates that medically attended anxiety and depression manifest at a higher rate in CAD patients than in a matched non-CAD cohort. Study findings suggest that CAD patients may experience a greater burden on mental health that may negatively contribute to their overall quality of life. Further investigation on this topic is warranted. Public Library of Science 2022-12-15 /pmc/articles/PMC9754177/ /pubmed/36520848 http://dx.doi.org/10.1371/journal.pone.0276617 Text en © 2022 Broome et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Broome, Catherine M.
Hooda, Naushin
Su, Jun
Jiang, Xiaohui
Nicholson, Gina
Frankenfeld, Cara L.
Iglesias-Rodriguez, Melitza
Fryzek, Jon
Patel, Parija
Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States
title Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States
title_full Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States
title_fullStr Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States
title_full_unstemmed Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States
title_short Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States
title_sort medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: analysis of an integrated claim-clinical cohort in the united states
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754177/
https://www.ncbi.nlm.nih.gov/pubmed/36520848
http://dx.doi.org/10.1371/journal.pone.0276617
work_keys_str_mv AT broomecatherinem medicallyattendedanxietyanddepressionisincreasedamongnewlydiagnosedpatientswithcoldagglutinindiseaseanalysisofanintegratedclaimclinicalcohortintheunitedstates
AT hoodanaushin medicallyattendedanxietyanddepressionisincreasedamongnewlydiagnosedpatientswithcoldagglutinindiseaseanalysisofanintegratedclaimclinicalcohortintheunitedstates
AT sujun medicallyattendedanxietyanddepressionisincreasedamongnewlydiagnosedpatientswithcoldagglutinindiseaseanalysisofanintegratedclaimclinicalcohortintheunitedstates
AT jiangxiaohui medicallyattendedanxietyanddepressionisincreasedamongnewlydiagnosedpatientswithcoldagglutinindiseaseanalysisofanintegratedclaimclinicalcohortintheunitedstates
AT nicholsongina medicallyattendedanxietyanddepressionisincreasedamongnewlydiagnosedpatientswithcoldagglutinindiseaseanalysisofanintegratedclaimclinicalcohortintheunitedstates
AT frankenfeldcaral medicallyattendedanxietyanddepressionisincreasedamongnewlydiagnosedpatientswithcoldagglutinindiseaseanalysisofanintegratedclaimclinicalcohortintheunitedstates
AT iglesiasrodriguezmelitza medicallyattendedanxietyanddepressionisincreasedamongnewlydiagnosedpatientswithcoldagglutinindiseaseanalysisofanintegratedclaimclinicalcohortintheunitedstates
AT fryzekjon medicallyattendedanxietyanddepressionisincreasedamongnewlydiagnosedpatientswithcoldagglutinindiseaseanalysisofanintegratedclaimclinicalcohortintheunitedstates
AT patelparija medicallyattendedanxietyanddepressionisincreasedamongnewlydiagnosedpatientswithcoldagglutinindiseaseanalysisofanintegratedclaimclinicalcohortintheunitedstates